Literature DB >> 17006617

Inhibition of cell proliferation and induction of apoptosis by genistein in experimental hepatocellular carcinoma.

Dechen Chodon1, S Mumtaz Banu, R Padmavathi, D Sakthisekaran.   

Abstract

Hepatocellular carcinoma (HCC) is the leading cause of cancer related deaths in the world, with increasing incidence in many developed countries. Epidemiological data suggest that consumption of soy products may be associated with a decreased risk of cancer. We investigate the effects of genistein on cell proliferation, apoptosis and caspase-3 in DEN induced (200 mg/kg body weight; by single intraperitoneal injection) and Phenobarbital promoted (0.05% through drinking water for 14 successive weeks) cancer-bearing rats. Immunohistochemistry was employed to detect cell proliferating markers proliferating cell nuclear antigen (PCNA), DNA fragmentation was determined by agarose gel electrophoresis and terminal deoxynucleatide transferase dUTP nick labeling (TUNEL) staining and caspase by enzyme-linked immunosorbent assay. We found inhibition of cell proliferation, induction of apoptosis and activation of caspase-3 in genistein treated animals. From these results, we conclude that genistein inhibit cell proliferation, induced apoptosis. This activation of caspsase-3 in genistein treated liver cancer bearing animals correlated well with its apoptosis inducing effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006617     DOI: 10.1007/s11010-006-9324-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  Limitations of the histopathological diagnosis and prognostic assessment of hepatocellular carcinoma.

Authors:  A Quaglia; S Bhattacharjya; A P Dhillon
Journal:  Histopathology       Date:  2001-02       Impact factor: 5.087

Review 2.  Apoptosis and the liver.

Authors:  S Kanzler; P R Galle
Journal:  Semin Cancer Biol       Date:  2000-06       Impact factor: 15.707

3.  Chemopreventive efficacy of selenium against N-nitrosodiethylamine-induced hepatoma in albino rats.

Authors:  C Thirunavukkarasu; J P Singh; K Selvendiran; D Sakthisekaran
Journal:  Cell Biochem Funct       Date:  2001-12       Impact factor: 3.685

Review 4.  The role of Fas-mediated apoptosis in thyroid disease.

Authors:  M Andrikoula; A Tsatsoulis
Journal:  Eur J Endocrinol       Date:  2001-06       Impact factor: 6.664

5.  Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells.

Authors:  L Faleiro; R Kobayashi; H Fearnhead; Y Lazebnik
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

6.  Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells.

Authors:  K R You; M N Shin; R K Park; S O Lee; D G Kim
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

Review 7.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

Review 8.  Genistein as an inducer of tumor cell differentiation: possible mechanisms of action.

Authors:  A Constantinou; E Huberman
Journal:  Proc Soc Exp Biol Med       Date:  1995-01

Review 9.  The evidence for soybean products as cancer preventive agents.

Authors:  A R Kennedy
Journal:  J Nutr       Date:  1995-03       Impact factor: 4.798

10.  Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.

Authors:  E A Slee; M T Harte; R M Kluck; B B Wolf; C A Casiano; D D Newmeyer; H G Wang; J C Reed; D W Nicholson; E S Alnemri; D R Green; S J Martin
Journal:  J Cell Biol       Date:  1999-01-25       Impact factor: 10.539

View more
  15 in total

Review 1.  Genistein and cancer: current status, challenges, and future directions.

Authors:  Carmela Spagnuolo; Gian Luigi Russo; Ilkay Erdogan Orhan; Solomon Habtemariam; Maria Daglia; Antoni Sureda; Seyed Fazel Nabavi; Kasi Pandima Devi; Monica Rosa Loizzo; Rosa Tundis; Seyed Mohammad Nabavi
Journal:  Adv Nutr       Date:  2015-07-15       Impact factor: 8.701

2.  Chemoprevention against hepatocellular carcinoma.

Authors:  Jun-Ichi Okano; Yuki Fujise; Ryo Abe; Ryu Imamoto; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2011-06-04

Review 3.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

4.  Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma.

Authors:  Yan Gu; Cheng-Fang Zhu; Ya-Lei Dai; Qiang Zhong; Bo Sun
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

5.  Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells.

Authors:  Yue Chen; Chaoqun Huang; Tianyan Zhou; Guangping Chen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-12       Impact factor: 4.080

6.  Proliferating cell nuclear antigen is protected from degradation by forming a complex with MutT Homolog2.

Authors:  Yu Yu; Jian-Ping Cai; Bo Tu; Lipeng Wu; Ying Zhao; Xiangyu Liu; Lian Li; Michael A McNutt; Jingnan Feng; Qihua He; Yang Yang; Haiying Wang; Mutsuo Sekiguchi; Wei-Guo Zhu
Journal:  J Biol Chem       Date:  2009-05-06       Impact factor: 5.157

7.  Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease.

Authors:  Christopher D Haines; Pamela A Harvey; Elizabeth D Luczak; Kristen K B Barthel; John P Konhilas; Peter A Watson; Brian L Stauffer; Leslie A Leinwand
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 8.  Anticancer activity of flavonoids accompanied by redox state modulation and the potential for a chemotherapeutic strategy.

Authors:  Yongkyu Lee; Jehyung Lee; Changbaek Lim
Journal:  Food Sci Biotechnol       Date:  2021-03-20       Impact factor: 2.391

9.  Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models.

Authors:  Elizabeth Hijona; Jesús María Banales; Lander Hijona; Juan Francisco Medina; Juan Arenas; Marta Herreros-Villanueva; Pablo Aldazabal; Luis Bujanda
Journal:  Cancer Cell Int       Date:  2012-02-21       Impact factor: 5.722

10.  Spiclomazine induces apoptosis associated with the suppression of cell viability, migration and invasion in pancreatic carcinoma cells.

Authors:  Wenjing Zhao; Dan Li; Zuojia Liu; Xiliang Zheng; Jin Wang; Erkang Wang
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.